Covaxin: Delhi HC refuses to stay order allowing Phase II, III trials on 2 to 18 year olds

The Delhi High Court has refused to stay the Centre’s notification which has accorded permission to conduct the Phase II/III clinical trial of Covaxin in the age group 2 to 18 years to its manufacturer Bharat Biotech Ltd.

However, the court issued notice to the Centre and Bharat Biotech to file their reply on a PIL against Covaxin’s clinical trials for age group 2 to 18.

Read Also: Appeal against IGST on oxygen concentrator gifts from abroad for personal use: Delhi HC reserves order

Source: ILNS
The post Covaxin: Delhi HC refuses to stay order allowing Phase II, III trials on 2 to 18 year olds appeared first on India Legal.